Language Selection

Français

Dried Blood Spot Testing

<<Return to Laboratory

Requisition Forms

Reference Details

Description:

HIV – Dried Blood Spot

Test Category:
Serology
Pathogen:
Human immunodeficiency virus (HIV)
Illnesses and Diseases:
  • Acquired immunodeficiency syndrome (AIDS)
Specimen:

HIV: Full dried blood spot card; 5 full circles optimal, <5 circles limits testing.

Collection Method:

See specimen above.

Specimen Processing, Storage and Shipping:

See Dried Blood Spot Collection, Packaging & Storage Guidelines.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

Please provide risk factors.

Accompanying Documentation:

NLHRS DBS Requisition: HIV, HCV, Syphilis & HBsAg

Comments:

See Dried Blood Spot Collection, Packaging & Storage Guidelines.

Methods and Interpretation of Results:

Varies for each test method, contact NLHRS for further information.

Turnaround Time:

Varies for each test method, contact NLHRS for further information.

Contact:
Phone #: (204) 789-6522
Fax: (204) 318-2221
References:
  1. Standard Council of Canada. SCC accredits first medical laboratory under new national program.  2008. http://www.scc.ca/en/news-events/news/2008/scc-accredits-first-medical-laboratory-under-new-national-program
  2. S.Lavoie, D. Caswell, M.J. Gill, K. Kadkhoda, C.L Charlton, P.N. Levett, T.Hatchette, R. Garceau, J. Maregmen, T. Mazzulli, R. Needle, K. Kadivar, J. Kim. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo Assay. Journal of Clinical Virology. 2018;104: 23-28
  3. Malloch L, Kadivar K, Putz J, Levett PN, Tang J, Hatchette TF, Kadkhoda K, Ng D, Ho J, Kim J. Comparative Evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an Alternative Differentiation Assay for CLSI M53 Algorithm-I. Journal of Clinical Virology. 2013;58, Supplement 1(0):e85-e91. http://www.sciencedirect.com/science/article/pii/S1386653213003326
  4. Kadivar K, Malloch L, Adonsou-Hoyi Y, Ng D, Lavoie S, Pulido K, Kim J. Would CLSI M53-A Have Helped in the Diagnosis of HIV in Canada? Results of the Performance of Canadian Laboratories Participating in a Recent NLHRS Proficiency Testing Panel Containing HIV-1 Antigen Positive (Antibody Negative) and HIV-2 Samples. Journal of Clinical Virology. 2013;58(1):303-305. http://www.sciencedirect.com/science/article/pii/S1386653213001303

 

Related Information: